Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies
Rattachement africain : us, gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Importance: Controlled substances have regulatory requirements under the US Federal Controlled Substance Act that must be met before pharmacies can stock and dispense them. However, emerging evidence suggests there are pharmacy-level barriers in access to buprenorphine for treatment for opioid use disorder even among pharmacies that dispense other opioids. Objective: To estimate the proportion of Medicaid-participating community retail pharmacies that dispense buprenorphine, out of Medicaid-participating community retail pharmacies that dispense other opioids and assess if the proportion dispensing buprenorphine varies by Medicaid patient volume or rural-urban location. Design, Setting, and Participants: This serial cross-sectional study included Medicaid pharmacy claims (2016-2019) data from 6 states (Kentucky, Maine, North Carolina, Pennsylvania, Virginia, West Virginia) participating in the Medicaid Outcomes Distributed Research Network (MODRN). Community retail pharmacies serving Medicaid-enrolled patients were included, mail-order pharmacies were excluded. Analyses were conducted from September 2022 to August 2023. Main Outcomes and Measures: The proportion of pharmacies dispensing buprenorphine approved for opioid use disorder among pharmacies dispensing an opioid analgesic or buprenorphine prescription to at least 1 Medicaid enrollee in each state. Pharmacies were categorized by median Medicaid patient volume (by state and year) and rurality (urban vs rural location according to zip code). Results: In 2016, 72.0% (95% CI, 70.9%-73.0%) of the 7038 pharmacies that dispensed opioids also dispensed buprenorphine to Medicaid enrollees, increasing to 80.4% (95% CI, 79.5%-81.3%) of 7437 pharmacies in 2019. States varied in the percent of pharmacies dispensing buprenorphine in Medicaid (range, 73.8%-96.4%), with significant differences between several states found in 2019 (χ2 P < .05), when states were most similar in the percent of pharmacies dispensing buprenorphine. A lower percent of pharmacies with Medicaid patient volume below the median dispensed buprenorphine (69.1% vs 91.7% in 2019), compared with pharmacies with above-median patient volume (χ2 P < .001). Conclusions and Relevance: In this serial cross-sectional study of Medicaid-participating pharmacies, buprenorphine was not accessible in up to 20% of community retail pharmacies, presenting pharmacy-level barriers to patients with Medicaid seeking buprenorphine treatment. That some pharmacies dispensed opioid analgesics but not buprenorphine suggests that factors other than compliance with the Controlled Substance Act influence pharmacy dispensing decisions.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies
- Date Crossref
- 17/05/2024
- Éditeur
- American Medical Association (AMA)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Kentucky Department of Pharmacy Practice and Science pays non établi dans la noticeUniversité ou école supérieure
-
University of Southern Maine pays non établi dans la noticeUniversité ou école supérieure
-
University of Pittsburgh pays non établi dans la noticeUniversité ou école supérieure
-
University of Utah pays non établi dans la noticeUniversité ou école supérieure
-
University of North Carolina at Chapel Hill pays non établi dans la noticeUniversité ou école supérieure
-
Men's Health Forum pays non établi dans la noticeOrganisation à but non lucratif
-
Northwestern University pays non établi dans la noticeUniversité ou école supérieure
-
Virginia Commonwealth University pays non établi dans la noticeUniversité ou école supérieure
-
Muskie School of Public Service pays non établi dans la noticeUniversité ou école supérieure
-
School of Public Health Department of Health Policy and Management pays non établi dans la noticeUniversité ou école supérieure
-
School of Medicine Department of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Associate Editor pays non établi dans la noticeInstitution
Department of Pharmacy Practice and Science — University of Kentucky, University of Southern Maine et University of Pittsburgh, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.